Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. uri icon

Overview

publication date

  • March 8, 2016

Identity

PubMed Central ID

  • PMC7297299

Scopus Document Identifier

  • 84973333090

Digital Object Identifier (DOI)

  • 10.1093/jac/dkw079

PubMed ID

  • 26960721

Additional Document Info

volume

  • 71

issue

  • 6